Active Chemopreventive Agent Development Grants

PI Namesort descending Organization - Company Title Project Number Fiscal Year
Liby, Karen T. Michigan State University Nrf2, immune cells and lung cancer 5R01CA226690-02 2020
Lipkin, Steven M Weill Medical Coll Of Cornell Univ Neoantigen Vaccination for Lynch Syndrome Immunoprevention 5U01CA233056-02 2019
Mallery, Susan R Ohio State University Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents 5R01CA211611-04 2020
Moon, James J University Of Michigan At Ann Arbor Engineering Nanomaterials to Prime Immunity 5R01CA210273-04 2020
Park, Youngkyu Cold Spring Harbor Laboratory Preclinical Models for Cancer Therapeutic Development 5R50CA211506-04 2019
Peters, Jeffrey M Pennsylvania State University-Univ Park Unique targeting of PPARβ/δ regulation for cancer prevention and therapy 1R01CA239256-01A1 2020
Piazza, Gary A University Of South Alabama Phosphodiesterase 10A, a novel target for lung cancer chemoprevention 5R01CA197147-05 2020
Piazza, Gary A University Of South Alabama Novel Sulindac Derivatives for Colon Cancer Chemoprevention 5R01CA131378-11 2019
Ramachandran, Ramesh Pennsylvania State University-Univ Park Metformin Supplementation for Ovarian Cancer Prevention: A Prospective Preclinical Study 5R03CA208573-02 2018
Rao, Chinthalapally V. University Of Oklahoma Hlth Sciences Ctr Safer Approaches to CRC Chemoprevention 5R01CA213987-04 2020
Robertson, Gavin P. Pennsylvania State Univ Hershey Med Ctr Targeting Aldehyde Dehydrogenase for Cancer Prevention 1R01CA241148-01A1 2020
Rodriguez, Gustavo Northshore University Healthsystem Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer 5R01CA214606-03 2020
Sempere, Lorenzo Michigan State University Chemical ablation of ductal tree for breast cancer prevention 5R21CA226579-02 2020
Sharp, Zelton Dave University Of Texas Hlth Science Center Delaying intestinal cancer 5R01CA193835-05 2020
Shen, Qiang University Of Tx Md Anderson Can Ctr Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 5R01CA226001-02 2019